4Dmt发布了来自湿性年龄相关性黄斑变性Prism 1/2期临床试验的积极长期数据,进一步支持了4D-150作为一种基础治疗的潜力,其效果显著且持续多年。
4Dmt发布了来自湿性年龄相关性黄斑变性Prism 1/2期临床试验的积极长期数据,进一步支持了4D-150作为一种基础治疗的潜力,其效果显著且持续多年。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.